Malhotra Neena, Noor Nilofar, Bansal Piyush, Sharma K Aparna
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Nagpur, India.
J Reprod Infertil. 2021 Jul-Sep;22(3):220-224. doi: 10.18502/jri.v22i3.6723.
Cesarean section scar ectopic pregnancy (CSEP) is a rare and potentially life-threatening condition. A standardized management protocol is yet to be established owing to limited data available.
In this paper, five cases of CSEP over a period of 18 months at a tertiary referral hospital, managed medically with methotrexate administered both systemically and into the gestational sac at the time of feticide with potassium chloride (KCL) are presented. Surgical management was the second line therapy when medical treatment failed.
With rising trends in cesarean deliveries, CSEP may be a challenge which requires close investigation regarding its diagnosis and treatment on the merits of case studies and available healthcare facilities.
剖宫产瘢痕部位异位妊娠(CSEP)是一种罕见且可能危及生命的疾病。由于可用数据有限,尚未建立标准化的管理方案。
本文介绍了一家三级转诊医院在18个月内发生的5例CSEP病例,采用甲氨蝶呤进行药物治疗,在使用氯化钾(KCL)杀胎时经全身及向妊娠囊内给药。药物治疗失败时,手术治疗作为二线治疗。
随着剖宫产率的上升,CSEP可能是一个挑战,需要根据病例研究和现有医疗设施的情况,对其诊断和治疗进行密切研究。